Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphomaMatthew J. Frigault, Marcela V. Maus, Jörg Dietrich et al.|Blood|2019Cited by 237
Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversityZachariah DeFilipp, Yi‐Bin Chen, Jonathan U. Peled et al.|Blood Advances|2018Cited by 206
Secondary solid cancer screening following hematopoietic cell transplantationYoshihiro Inamoto, Navneet S. Majhail, Mehdi Hamadani et al.|Bone Marrow Transplantation|2015Cited by 185
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular TherapyMohamed A. Kharfan‐Dabaja, Marcie Riches, Ambuj Kumar et al.|Transplantation and Cellular Therapy|2021Cited by 180
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTZachariah DeFilipp, Bronwen E. Shaw, Rafael F. Duarte et al.|Biology of Blood and Marrow Transplantation|2016Cited by 64